Protalix BioTherapeutics
PLX | AMEX
$3.03
-$0.02 (-0.66%)
At close: Nov 16, 2026, 4:00 PM ET
$2.98
-$0.05 (-1.65%)
After-hours:
Nov 16, 2026, 7:17 PM ET
-0.66%
(1D)No price chart data available for 1D timeframe.
Rating
87
+3.0 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #3/1021 (Top 1%)
Key Statistics
Market Data
Market Cap $255.49M
1D Range
2.96 3.07
52W Range
1.67 3.15
Valuation (TTM)
PE 12.12
PB 3.17
EV/EBITDA 7.57
Valuation (NTM)
Forward PE 10.89
Forward PEG 0.01
Price Target $6.00
Cash Flow
FCF Yield 5.9%
SBC Adj. FCF Yield 5.0%
SBC Impact -15.0%
Margins
Gross Margin 71.2%
Operating Margin 29.8%
FCF Margin 17.8%
Growth (CAGR)
Revenue 3Y | 5Y 10.0% |
11.4%
Dil EPS 3Y | 5Y 56.6% |
470.4%
FCF 3Y | 5Y 112.3% |
158.4%
Returns
ROA 17.4%
ROE 30.7%
ROIC 22.3%
Financial Health
Net Cash
$48.54M
Current Ratio 3.27
Interest Coverage 23.04
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based p...
Sector Healthcare
Industry Biotechnology
Employees 226
IPO Date May 15, 1998
Website www.protalix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
$0.05
Beat +350.00%
YoY:
+66.67% REV
$21.93M
Beat +76.53%
YoY:
+22.82%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+98.02%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PLX